908 DEVICES INC. (MASS) Gross Margin
- Gross margin · 12 months: Value 52.16%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 52.16% | Gross profit / revenue. Period ending 2026-06-30. $31.73M ÷ $60.84M × 100 ≈ 52.16% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 31.73M USD | Gross Profit |
| Revenue | 60.84M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $31.73M | $60.84M | (m) | 52.16% |
| 2026-03-31 | $29.76M | $57.80M | (m) | 51.49% |
| 2025-12-31 | $28.42M | $56.20M | (m) | 50.58% |
| 2025-09-30 | $31.30M | $65.05M | (m) | 48.12% |
| 2025-06-30 | $31.72M | $65.56M | (m) | 48.39% |
| 2025-03-31 | $31.51M | $63.99M | (m) | 49.25% |
| 2024-12-31 | $29.86M | $59.63M | (m) | 50.07% |
| 2024-09-30 | $28.03M | $55.16M | (m) | 50.81% |
| 2024-06-30 | $27.57M | $52.69M | (m) | 52.32% |
| 2024-03-31 | $25.94M | $50.73M | (m) | 51.13% |
| 2023-12-31 | $25.32M | $50.23M | (m) | 50.41% |
| 2023-09-30 | $23.97M | $47.52M | (m) | 50.44% |
| 2023-06-30 | $25.44M | $49.02M | (m) | 51.89% |
| 2023-03-31 | $26.28M | $48.03M | (m) | 54.71% |
| 2022-12-31 | $26.02M | $46.85M | (m) | 55.54% |
| 2022-09-30 | $29.23M | $51.05M | (m) | 57.27% |
| 2022-06-30 | $26.71M | $47.80M | (m) | 55.88% |
| 2022-03-31 | $24.45M | $44.97M | (m) | 54.38% |
| 2021-12-31 | $23.23M | $42.21M | (m) | 55.05% |
| 2021-09-30 | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) |
| 2020-12-31 | $14.92M | $26.89M | (m) | 55.49% |
| 2020-09-30 | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |